UTAH MEDICAL PRODUCTS INC (UTMD) Latest Filing Signal

Latest Filing: 10-K  |  Filed Mar 27, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for UTAH MEDICAL PRODUCTS INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, UTAH MEDICAL PRODUCTS INC's filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Continuing Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does UTAH MEDICAL PRODUCTS INC actually do?
Answer:
Utah Medical Products, Inc. (UTMD) designs, manufactures, and distributes specialized medical devices focused on safety and improved patient outcomes, particularly in critical care areas like neonatal intensive care (NICU) and labor and delivery (L&D). The company's success hinges on identifying clinical needs, developing cost-effective solutions, and selling through direct channels or strategic partnerships. UTMD leverages expertise in electronics, software, and mechanical engineering to create differentiated products that offer significant improvements over existing methods. Its product portfolio includes fetal monitoring accessories, specialized labor and delivery tools, neonatal care devices, electrosurgical instruments, and the Filshie Clip System for permanent contraception, with 41% of its 2025 sales generated outside the U.S.
Question:
What are UTAH MEDICAL PRODUCTS INC's revenue drivers?
Answer:
Revenue is primarily driven by the sale of specialized medical devices across four categories: obstetrics, gynecology/electrosurgery/urology, neonatal critical care, and blood pressure monitoring/accessories/other. A significant portion of revenue also comes from OEM sales of components and finished devices to other companies.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required